Giapreza
Active Ingredient(s): Angiotensin IIFDA Approved: * December 21, 2017
Pharm Company: * LA JOLLA PHARM CO
Category: Blood Pressure
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Giapreza Overview
2WXW, 2X0B, 4APH,%%s1N9U, 1N9V,%%s1N9V, 1N9U, 3CK0, 4AA1, 4APH, 5E2QIdentifiersAliasesAGT, ANHU, SERPINA8, hFLT1, angiotensinogenExternal IDsMGI: 87963 HomoloGene: 14 GeneCards: AGT Gene location (Human)Chr.Chromosome 1 (human)[1]Band1q42.2Start230,702,523 bp[1]End230,714,122 bp[1]Gene location (Mouse)Chr.Chromosome 8 (mouse)[2]Band8 E2|8 72.81 cMStart124,556,534 bp[2]End124,569,706 bp[2]R...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Angiotensin
Recent Giapreza Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Angiotensin II
- Solution: 2.5mg/ml (2.5mg/ml), 5mg/2ml (2.5mg/ml)
NDC Database Records for Giapreza: (1 result)
Sorted by National Drug Code- 68547-501 Giapreza 2.5 mg/ml Intravenous Injection by La Jolla Pharmaceutical Company